glp 1 no longer available New research shows heart benefits fade after stopping GLP-1 medications. Experts break down what to know Cost Dominates GLP-1 Treatment Decisions

TABLE 1 Carbon quantum dot (CQD) precursors and synthesis methods from biomass sources

In the SURMOUNT-1 study, a phase 3 clinical trial in obese patients, randomized participants in a 1:1:1:1 ratio to tirzepatide (5, 10, 15 mg) or placebo over 72 weeks, significant weight reductions were observed at 72 weeks: 15.0% for 5 mg, 19.5% for 10 mg, 20.9% for 15 mg, compared to 3.1% for placebo [18]

Many people report feeling a difference in their general energy and wellness after 2 to 4 weeks of consistent use, though long-term cellular benefits continue to accumulate over time.

Have more energy and feel good but have had NO weight lose and that is why I purchased

In the 2022 SURMOUNT-1 study published in NEJM, three doses of tirzepatide were compared with placebo (1:1:1:1) to determine effects on percent weight change over the course of 72 weeks